{{Rsnum
|rsid=301
|Gene=LPL
|Chromosome=8
|position=19959423
|Orientation=plus
|GMAF=0.4247
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=LPL
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 32.7 | 58.4
| HCB | 2.9 | 31.6 | 65.4
| JPT | 7.1 | 27.4 | 65.5
| YRI | 4.1 | 47.6 | 48.3
| ASW | 5.3 | 50.9 | 43.9
| CHB | 2.9 | 31.6 | 65.4
| CHD | 5.5 | 33.0 | 61.5
| GIH | 2.0 | 28.7 | 69.3
| LWK | 6.4 | 39.1 | 54.5
| MEX | 5.2 | 29.3 | 65.5
| MKK | 6.5 | 44.5 | 49.0
| TSI | 5.9 | 36.3 | 57.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21386085
|Trait=None
|Title=A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium
|RiskAllele=C
|Pval=3E-11
|OR=0.2200
|ORtxt=[0.16-0.28] unit decrease
|OA=1
}}

{{PMID Auto
|PMID=19148283
|Title=Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=19913121
|Title=Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}